• S&P 500: 1,351.95
  • Change: 0.00%
$31.49 0.00 (0%)
2/25/2011 5:00 PM

Martek Biosciences Corp. (NASDAQ:MATK)

CAPS Rating: 5 out of 5

Develops and commercializes products derived from microalgae, fungi and other microbes. Products are nutritional oils used as ingredients in infant formula and foods, and as ingredients in and encapsulated for use as dietary supplements.

Current Price $31.49 Mkt Cap $1.06B
Open $0.00 P/E Ratio 38.00
Prev. Close $31.49 Div. (Yield) N/A (N/A)
Daily Range $31.48 - $31.54 Volume 0
52-Wk Range $17.95 - $32.75 Avg. Daily Vol. 0

News & Discussion Boards

More Headlines...

Sorry no news articles available for MATK.

More Fool Articles...

Sorry no Fool articles available for MATK.

Subject Recs Author Date

Caps

This ticker is not currently Ratable.

All Players

346 Outperform
18 Underperform
 

All-Star Players

64 Outperform
3 Underperform
 

Wall Street

4 Outperform
0 Underperform
 

Top MATK Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

pwalls01 (28.19)
Submitted April 24, 2008

Develops and commercializes products derived from microalgae, fungi and other microbes. Products are nutritional oils used as ingredients in infant formula and foods, and as ingredients in and encapsulated for use as dietary supplements.

alexferrari (< 20)
Submitted October 11, 2006

DHA powder is too expensive to be acepted by food manufacturers. DHA oil is not stable enough to be used in most food applications. Martek's oil will perform only as a niche product in some vegetarian foods.

MATK VS S&P 500 (SPY)

Fools bullish on MATK are also bullish on:

Fools bearish on MATK are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about MATK.

Recs

0
Member Avatar alfred13 (88.89) Submitted: 11/3/2010 10:10:35 AM : Outperform Start Price: $22.43 MATK Score: +27.28

This is a company that I have been watching for some time, and I have been concerned if this company could handle the growth and whether it could take advantage of being out front in a growth opportunity. Now I think the answer is that it can and that it can.

Recs

0
Member Avatar Investin1 (< 20) Submitted: 12/29/2009 2:22:07 AM : Underperform Start Price: $19.41 MATK Score: -42.46

DHP derived from algae is more costly to produce than that from fish. The market has already been fully penetrated for DHP, and adult sales show very little in terms of growth prospects for the company. The company many have decent cash flow, but the cash is not headed towards R&D.

Recs

0
Member Avatar unicornhunter7 (94.96) Submitted: 12/21/2009 11:04:49 AM : Outperform Start Price: $18.49 MATK Score: +48.88

The nutritional oils it makes are added to baby formulas, and they are being adopted by more countries. It has signed contracts with companies in Spain and China, and is trying to find uses outside the baby formula markket. I am looking ahead a few years, and like the possibilities.

Leaderboard

Find the members with the highest scoring picks in MATK.

Score Leader

DranoeLX

DranoeLX (< 20) Score: +64.71

The Score Leader is the player with the highest score across all their picks in MATK.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
rumblinantstanda 97.72 12/1/2009 Outperform 5Y $17.48 +80.15% +22.03% +58.11 0 Comment
rumblinantfool 95.72 12/1/2009 Outperform 5Y $17.48 +80.15% +22.03% +58.11 0 Comment
rumblinantliquid 87.32 12/1/2009 Outperform 5Y $17.48 +80.15% +22.03% +58.11 0 Comment
piibu < 20 12/3/2009 Outperform 3Y $17.45 +80.46% +22.46% +57.99 0 Comment
biofest 38.07 12/7/2009 Outperform 5Y $17.67 +78.21% +22.04% +56.17 1 Comment
sewserious 89.37 3/22/2007 Outperform NS $20.31 +55.05% -0.11% +55.16 0 Comment
pmcd1983 99.37 3/22/2007 Outperform 5Y $20.34 +54.82% -0.15% +54.97 0 Comment
Pranab74 < 20 3/27/2007 Outperform 1Y $20.39 +54.44% -0.01% +54.45 1 Comment
baisleyde 72.81 3/27/2007 Outperform NS $20.37 +54.59% +0.25% +54.34 0 Comment
OverAnalyze 60.29 3/30/2007 Outperform 3W $20.30 +55.12% +0.98% +54.14 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackCantorFitz 52.42 3/25/2009 Outperform NS $17.25 +82.55% +68.19% +14.36 0 Comment
TrackNorthlandSe 89.17 3/19/2009 Outperform NS $17.88 +76.85% +54.71% +22.13 12/21/2010 @ $31.62 0 Comment
TrackScottBleier 92.83 12/28/2007 Outperform 3M $29.37 +7.22% -4.23% +11.45 0 Comment
TrackBroadpointAmTech 90.21 10/8/2007 Outperform NS $30.48 +3.31% -8.65% +11.96 0 Comment
TrackSoros 93.24 9/30/2007 Outperform NS $29.03 +5.30% -13.94% +19.25 3/31/2008 @ $30.57 1 Comment
TrackNeedham 92.43 9/7/2006 Outperform NS $21.91 +43.72% +2.73% +41.00 4/1/2011 @ $31.49 0 Comment
TrackJimCramer 78.02 3/10/2006 Outperform 3W $33.09 -4.84% +13.13% -17.97 0 Comment

Featured Broker Partners